Tech Company Financing Transactions
Babson Diagnostics Funding Round
Babson Diagnostics, based in Austin, scored $31 million from Emerald Development Managers, LAGO Consulting & Services and Prism VentureWorks.
Transaction Overview
Company Name
Announced On
6/30/2021
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series B
Investors
Emerald Development Managers (Lead Investor) (Neil Cohen)
Proceeds Purpose
The Series B fundraise will accelerate the commercialization of Babson's disruptive technology that will make routine blood testing easier, more accessible, and less invasive.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1205 Sheldon Cove 2-J
Austin, TX 78753
USA
Austin, TX 78753
USA
Phone
Undisclosed
Website
Email Address
Overview
Improving the customer experience of diagnostic blood testing without sacrificing accuracy or cost. With humble gratitude, we honor those who helped to shape and foster our vision. Inspired by our hero Art Babson and incubated at Siemens Healthineers, we launched as an independent startup in 2017 with a mission to make diagnostic blood testing more convenient, accessible, and human.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Stein
Chief Operating Officer
Eric Olson
VP - R & D
Roy Barr
VP - Regulatory Affairs
James Jacobson
Browse more venture capital transactions:
Prev: 6/30/2021: Retina venture capital transaction
Next: 6/30/2021: Harness Wealth venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs